Streetbeat News

HSTO

Histogen Inc

https://www.conatuspharma.com/

CEO

Steven Mento

Employees

Industry

Pharmaceutical Preparation Manufacturing

a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor. two product families - a proprietary liquid complex of embryonic-like proteins and growth factors, and a human extracellular matrix (ecm) material, exceltrix.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

During Thursday's intraday session, several healthcare stocks experienced significant movements. Orchard Therapeutics, Histogen, Clene, Orgenesis, Omega Therapeutics, and Matinas BioPharma Hldgs saw their shares increase by 96.5%, 47.17%, 21.0%, 19.98%, 19.4%, and 15.85% respectively. On the other hand, MaxCyte, Longeveron, Viracta Therapeutics, Nanobiotix, SenesTech, and Renalytix saw their shares decline by 22.6%, 17.93%, 17.39%, 17.14%, 16.29%, and 16.11% respectively.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 5:31 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Vivos Therapeutics (VVOS), Nuvalent (NUVL), Histogen (HSTO), MiNK Therapeutics (INKT), Brainstorm Cell (BCLI), and Gritstone Bio (GRTS) saw their shares rise, with VVOS leading the gainers with a 105.4% increase. On the other hand, Inhibikase Therapeutics (IKT), Protagenic Therapeutics (PTIX), Standard BioTools (LAB), Nuwellis (NUWE), Lipella Pharmaceuticals (LIPO), and MSP Recovery (LIFW) saw their shares fall, with IKT leading the losers with a 33.2% decrease.

Portfolio Pulse from Benzinga Insights

October 04, 2023 | 5:31 pm

The article lists the stocks that have gained and lost the most in Wednesday's mid-day session. Gaucho Group Holdings, Vivos Therapeutics, and Conduit Pharmaceuticals were among the top gainers, while Molekule Group, A10 Networks, and Inhibikase Therapeutics were among the top losers. Cal-Maine Foods shares fell by around 8% due to weaker-than-expected sales for its first quarter.

Portfolio Pulse from Lisa Levin

October 04, 2023 | 4:48 pm

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Notable gainers included Sonendo (SONX), PureTech Health (PRTC), Phio Pharma (PHIO), Histogen (HSTO), China Pharma Holding (CPHI), and Aditxt (ADTX). On the other hand, MSP Recovery (LIFW), Aclarion (ACON), Femasys (FEMY), Petros Pharma (PTPI), Novo Integrated Sciences (NVOS), and Tenon Medical (TNON) saw declines.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 9:31 pm

The article lists the stocks that gained and lost the most in Wednesday's mid-day session. Among the gainers were MSP Recovery, Digital Transformation Opportunities Corp., Bluejay Diagnostics, Fresh Tracks Therapeutics, and AgriFORCE Growing Systems. Among the losers were Seelos Therapeutics, ARS Pharmaceuticals, Connexa Sports Technologies, Molekule Group, and IceCure Medical.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 6:10 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Gainers included MSP Recovery (LIFW), Fresh Tracks Therapeutics (FRTX), Bluejay Diagnostics (BJDX), Evaxion Biotech (EVAX), Histogen (HSTO), and TransCode Therapeutics (RNAZ). Losers included Seelos Therapeutics (SEEL), ARS Pharmaceuticals (SPRY), Longeveron Inc. - Subscription Right (LGVNR), Biolase (BIOL), Butterfly Network (BFLY), and Sonoma Pharmaceuticals (SNOA).

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 5:31 pm

During Wednesday's pre-market session, several healthcare stocks experienced significant movements. Bluejay Diagnostics, TransCode Therapeutics, Fresh Tracks Therapeutics, Histogen, MSP Recovery, and Exscientia saw their shares increase, while Seelos Therapeutics, ARS Pharmaceuticals, Elutia, Heart Test Laboratories, Regulus Therapeutics, and Akili experienced a decrease in their stock prices.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 1:06 pm

Shares of several companies including TransCode Therapeutics, Fresh Tracks Therapeutics, EBET, Exscientia, Histogen, Rail Vision, Avinger, Inhibikase Therapeutics, Microbot Medical, and Cheche Group are trading higher in pre-market. Fresh Tracks Therapeutics and Histogen announced plans of liquidation and dissolution. Exscientia and Merck announced collaboration on AI-driven drug discovery. Avinger announced the commercial launch of its Tigereye ST image-guided CTO crossing device. On the other hand, shares of ARS Pharmaceuticals, Connexa Sports Technologies, Bird Global, TD Holdings, AgileThought, Elutia, Digital Transformation Opportunities Corp., Cybin, and Revance Therapeutics are trading lower. ARS Pharmaceuticals received a Complete Response Letter from the FDA for its neffy® Epinephrine nasal spray. Bird Global announced its purchase of micromobility operator Skinny Labs for $19 million. Elutia announced a $26 million private placement of shares.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 12:19 pm

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Fresh Tracks Therapeutics, Histogen, Avinger, Longeveron Inc. - Subscription Right, Bluejay Diagnostics, and Exagen saw increases, while Novo Integrated Sciences, ContraFect, HilleVax, IN8bio, Cardio Diagnostics Hldgs, and OKYO Pharma experienced declines.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 9:31 pm

US stocks traded lower with the Dow Jones falling more than 150 points. AutoZone Inc reported better-than-expected earnings for its fourth quarter. Rackspace Technology, Avinger, and Elutia Inc shares shot up after positive news. 60 Degrees Pharmaceuticals, Histogen Inc, and Revance Therapeutics shares dropped due to negative developments. The FOMC starts its two-day policy meeting today.

Portfolio Pulse from Lisa Levin

September 19, 2023 | 6:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.